A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
about
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Biomarker Study in Advanced ...... in Combination With Ipilimumab
@en
type
label
A Biomarker Study in Advanced ...... in Combination With Ipilimumab
@en
prefLabel
A Biomarker Study in Advanced ...... in Combination With Ipilimumab
@en
P1050
P1476
A Study to Estimate the Anti-T ...... lowed by Nivolumab Monotherapy
@en
P3098
NCT02978443
P580
2016-12-01T00:00:00Z
P582
2019-12-01T00:00:00Z